Shigella flexneri Inhibits Intestinal Inflammation by Modulation of Host Sphingosine-1-Phosphate in Mice
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Infection with invasive Shigella species results in intestinal inflammation in humans but no symptoms in adult mice. To investigate why adult mice are resistant to invasive shigellae, 6∼8-week-old mice were infected orally with S. flexneri 5a. Shigellae successfully colonized the small and large intestines. Mild cell death was seen but no inflammation. The infected bacteria were cleared 24 hours later. Microarray analysis of infected intestinal tissue showed that several genes that are involved with the sphingosine-1-phosphate (S1P) signaling pathway, a lipid mediator which mediates immune responses, were altered significantly. Shigella infection of a human intestinal cell line modulated host S1P-related genes to reduce S1P levels. In addition, co-administration of S1P with shigellae could induce inflammatory responses in the gut. Here we propose that Shigella species have evasion mechanisms that dampen host inflammatory responses by lowering host S1P levels in the gut of adult mice.
Abstract
Infection with invasive Shigella species results in intestinal inflammation in humans but no symptoms in adult mice. To investigate why adult mice are resistant to invasive shigellae, 6∼8-week-old mice were infected orally with S. flexneri 5a. Shigellae successfully colonized the small and large intestines. Mild cell death was seen but no inflammation. The infected bacteria were cleared 24 hours later. Microarray analysis of infected intestinal tissue showed that several genes that are involved with the sphingosine-1-phosphate (S1P) signaling pathway, a lipid mediator which mediates immune responses, were altered significantly. Shigella infection of a human intestinal cell line modulated host S1P-related genes to reduce S1P levels. In addition, co-administration of S1P with shigellae could induce inflammatory responses in the gut. Here we propose that Shigella species have evasion mechanisms that dampen host inflammatory responses by lowering host S1P levels in the gut of adult mice.
참고문헌 (24)
- Kotloff, K. L., "Global burden of Shigella infections: implications for vaccine development and implementation of control strategies", Bull. World Health Organ, 77, pp.651~666 (1999)
- Ogawa, M., "The versatility of Shigella effectors", Nat. Rev. Microbiol, 6, pp.11~16 (2008)
- Kweon, M. N., "Shigellosis: the current status of vaccine development", Curr. Opin. Infect. Dis, 21, pp.313~318 (2008)
- Ashida, H., "Shigella are versatile mucosal pathogens that circumvent the host innate immune system", Curr. Opin. Immunol, 23, pp.448~455 (2011)
- Shim, D. H., "New animal model of shigellosis in the Guinea pig: its usefulness for protective efficacy studies", J. Immunol, 178, pp.2476~2482 (2007)
- Fernandez, M. I., "A newborn mouse model for the study of intestinal pathogenesis of shigellosis", Cell. Microbiol, 5, pp.481~491 (2003)
- Shim, D. H., "Defensins play a crucial role in protecting mice against oral Shigella flexneri infection", Biochem. Biophys. Res. Commun, 401, pp.554~560 (2010)
- Ashida, H, "Cell death and infection: a double-edged sword for host and pathogen survival", J. Cell Biol, 195, pp.931~942 (2011)
- Bergsbaken, T., "Pyroptosis: host cell death and inflammation", Nat. Rev. Microbiol, 7, pp.99~109 (2009)
- Sanada, T., "The Shigella flexneri effector OspI deamidates UBC13 to dampen the inflammatory response", Nature, 483, pp.623~626 (2012)
- Ogawa, M, "Escape of intracellular Shigella from autophagy", Science, 307, pp.727~731 (2005)
- Ogawa, M., "A Tecpr1-dependent selective autophagy pathway targets bacterial pathogens", Cell Host. Microbe, 9, pp.376~389 (2011)
- Chang, S. Y., "Autophagy controls an intrinsic host defense to bacteria by promoting epithelial cell survival: a murine model", PLoS One, 8, pp.e81095~ (2013)
- Yang, J. Y, "A mouse model of shigellosis by intraperitoneal infection", J. Infect. Dis, 209, pp.203~215 (2014)
- Le Stunff, H., "Role of sphingosine-1-phosphate phosphatase 1 in epidermal growth factor-induced chemotaxis", J. Biol. Chem, 279, pp.34290~34297 (2004)
- Ashida, H, "Bacteria and host interactions in the gut epithelial barrier", Nat. Chem. Biol, 8, pp.36~45 (2011)
- Sansonetti, P. J., "Shigellosis: an old disease in new clothes?", PLoS Med, 3, pp.e354~ (2006)
- Le Stunff, H., "Generation and metabolism of bioactive sphingosine-1-phosphate", J. Cell. Biochem, 92, pp.882~899 (2004)
- Spiegel, S., "The outs and the ins of sphingosine-1-phosphate in immunity", Nat. Rev. Immunol, 11, pp.403~415 (2011)
- Chi, H., "Sphingosine-1-phosphate and immune regulation: trafficking and beyond", Trends Pharmacol. Sci, 32, pp.16~24 (2011)
- Alvarez, S. E, "Sphingosine-1-phosphate is a missing cofactor for the E3 ubiquitin ligase TRAF2", Nature, 465, pp.1084~1088 (2010)
- Teijaro, J. R., "Endothelial cells are central orchestrators of cytokine amplification during influenza virus infection", Cell, 146, pp.980~991 (2011)
- Ashida, H., "Shigella infection of intestinal epithelium and circumvention of the host innate defense system", Curr. Top. Microbiol. Immunol, 337, pp.231~255 (2009)
- Tran Van Nhieu, G., "Bacterial signals and cell responses during Shigella entry into epithelial cells", Cell. Microbiol, 2, pp.187~193 (2000)